
Ben Ackerman
Director of Real-world Biostatistics at GSK; PhD in Biostatistics from Johns Hopkins; expert in causal inference and measurement error in clinical trials and real-world evidence studies
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
Jun 9, 2026
Understanding and Mitigating Endpoint Bias in External Control Arms
8:39
8:56
9:37
9:42

Ben AckermanGUEST
I think the short answer is it depends on what data you have and how well you understand the comparison between what is measured in a trial and what's available in these, whether it's clinical notes or what's available in the comparator arm.

Ben AckermanGUEST
So to that point, I think the best way to mitigate those differences is to have some validation study conducted or some data available where you can, for each patient, directly compare these two different methods of the outcome, where you can say, "Okay, on, on this visit there was imaging done, and per certain criteria it was determined that the patient was responding to treatment." And then you also have some version on that same day for that same patient that says what sort of is documented in that EHR system.

Ben AckermanGUEST
A- and you can then compare how often do they draw the same conclusion, how often do they not.

Ben AckermanGUEST
And then you can use those metrics of sensitivity or specificity in this validation study and use those metrics to adjust your analyses in future studies.
9 MINS LATER
18:43
In terms of that, do you have any experience in terms of documenting these things and pre-specification in term achieving transparency?
